RIBI IMMUNOCHEM RESEARCH INC (CIK: 0000352331) EDGAR, Information, Filings... CompaniesBIO.Com

RIBI IMMUNOCHEM RESEARCH INC

Mailing address
553 OLD CORVALLIS ROAD, HAMILTON, Delaware, 59840-3131
Phone
4063636214
State location
Montana
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

RIBI IMMUNOCHEM RESEARCH INC (CIK: 0000352331) is an American company incorporated in the state of Montana. Head office is located at 553 OLD CORVALLIS RD, HAMILTON, Montana, 59840. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). RIBI IMMUNOCHEM RESEARCH INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RIBI IMMUNOCHEM RESEARCH INC

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000352331-99-000011 ( Act) Size: 3 KB	Oct-08-1999	000-11094 99725192
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000891020-99-001462 ( Act) Size: 7 KB	Aug-19-1999	000-11094 99696216
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000352331-99-000009 ( Act) Size: 49 KB	Aug-11-1999	000-11094 99683570
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000352331-99-000007 ( Act) Size: 43 KB	May-12-1999	000-11094 99618079
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000860655-99-000046 ( Act) Size: 29 KB	Apr-09-1999	005-35981 99590833
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000352331-99-000003 ( Act) Size: 220 KB	Mar-26-1999	000-11094 99573744
DEF 14A	Document	Definitive proxy statements Acc-no: 0001047469-99-009520 ( Act) Size: 47 KB	Mar-12-1999	000-11094 99563922
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000860655-99-000029 ( Act) Size: 29 KB	Feb-12-1999	005-35981 99537200
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000889812-99-000170 ( Act) Size: 8 KB	Jan-21-1999	005-35981 99509087
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000352331-98-000016 ( Act) Size: 48 KB	Nov-13-1998	000-11094 98748808
8-K	Document	Current report filing Acc-no: 0000352331-98-000014 ( Act) Size: 10 KB	Nov-06-1998	000-11094 98738905
S-3/A	Document	Amendment to Registration statement for specified transactions by certain issuers Acc-no: 0000352331-98-000011 ( Act) Size: 79 KB	Oct-05-1998	333-61435 98721074
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0000352331-98-000008 ( Act) Size: 72 KB	Aug-14-1998	333-61435 98686923
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000352331-98-000006 ( Act) Size: 116 KB	Aug-13-1998	000-11094 98684338
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000352331-98-000004 ( Act) Size: 37 KB	May-14-1998	000-11094 98620016
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000893220-98-000669 ( Act) Size: 11 KB	Apr-03-1998	005-35981 98587393
10-K405	Document	Acc-no: 0000352331-98-000002 ( Act) Size: 170 KB	Mar-25-1998	000-11094 98572698
DEF 14A	Document	Definitive proxy statements Acc-no: 0001047469-98-010709 ( Act) Size: 47 KB	Mar-20-1998	000-11094 98569727
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000889812-98-000357 ( Act) Size: 14 KB	Feb-10-1998	005-35981 98529679
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000893220-98-000020 ( Act) Size: 17 KB	Jan-09-1998	000-11094 98504263

Recent 20 filings. View all RIBI IMMUNOCHEM RESEARCH INC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

RIBI IMMUNOCHEM RESEARCH INC overview
RIBI IMMUNOCHEM RESEARCH INC job
RIBI IMMUNOCHEM RESEARCH INC stock
RIBI IMMUNOCHEM RESEARCH INC ownership
RIBI IMMUNOCHEM RESEARCH INC CEO
RIBI IMMUNOCHEM RESEARCH INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.